Skip to Main Content

Paper Details

A glycolytic phenotype is associated with prostate cancer progression and aggressiveness: a role for monocarboxylate transporters as metabolic targets for therapy.
J Pathol
87
2015
Author NameAffiliation
Charlie E MassieCancer Research UK (CRUK) Cambridge Institute
David E NealCancer Research UK (CRUK) Cambridge Institute
David E NealUniversity of Cambridge, Addenbrooke's Hospital
  • 1 - 3

Datasets

Release 1.2